Early 21st Century renal cell carcinoma

A “paradigm shift”

Authors

  • Massimo Lazzeri MD, PhD,

    Corresponding author
    1. Department of Urology, Vita-Salute University, San Raffaele Hospital, Turro, Milan, Italy
    • Department of Urology, San Raffaele Hospital, Vita-Salute University, San Raffaele Turro, Via Stamira D'Ancona 20, 20127 Milan, Italy
    Search for more papers by this author
  • Giorgio Guazzoni MD

    1. Department of Urology, Vita-Salute University, San Raffaele Hospital, Turro, Milan, Italy
    Search for more papers by this author

  • We thank Amy Sussman for the linguistic revision of the article.

  • See referenced original articles on pages 3119-26 and 3135-42, this issue.

Abstract

Individuals involved in the management of patients with small renal masses should acknowledge the role and the importance of active surveillance in older populations (aged >75 years) and minimally invasive ablative therapies. These new therapeutic strategies should be inculcated during medical training and practice so that they may become just as embedded as the emphasis on the oncologic outcome of standard treatment.

Ancillary